17-82433808-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001330542.2(HEXD):āc.433A>Gā(p.Ile145Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.377 in 1,611,518 control chromosomes in the GnomAD database, including 126,366 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001330542.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEXD | NM_001330542.2 | c.433A>G | p.Ile145Val | missense_variant | 5/13 | ENST00000327949.15 | NP_001317471.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEXD | ENST00000327949.15 | c.433A>G | p.Ile145Val | missense_variant | 5/13 | 1 | NM_001330542.2 | ENSP00000332634.9 |
Frequencies
GnomAD3 genomes AF: 0.428 AC: 65123AN: 152064Hom.: 15255 Cov.: 33
GnomAD3 exomes AF: 0.450 AC: 110502AN: 245678Hom.: 28939 AF XY: 0.434 AC XY: 58025AN XY: 133788
GnomAD4 exome AF: 0.372 AC: 542627AN: 1459336Hom.: 111070 Cov.: 36 AF XY: 0.371 AC XY: 269402AN XY: 725982
GnomAD4 genome AF: 0.429 AC: 65216AN: 152182Hom.: 15296 Cov.: 33 AF XY: 0.433 AC XY: 32186AN XY: 74400
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at